Financial Data and Key Metrics Changes - Revenue for the 12-month period grew 12% year-over-year, reaching BRL 3,697 million, with adjusted EBITDA growth of over 50% year-over-year, reaching BRL 1,680 million [4][5] - Adjusted EBITDA margin for the same period reached 45.4%, an increase of 130 basis points over last year [4][25] - Net income reached BRL 768.4 million, an 18% growth year-over-year, with basic EPS reaching BRL 8.32, a 19% increase compared to last year [5][26] - Cash flow from operating activities ended the 12-month period at BRL 1,548 million, over 6% higher than last year, with a cash conversion of 93.7% [4][25] Business Line Data and Key Metrics Changes - The number of undergraduate medical students grew by 5% year-over-year, reaching over 25,000 students, with approved medical seats increasing by 5% [19] - Continuing education segment revenue grew by 11% year-over-year, reaching BRL 284 million, with B2B revenue growth at 48% [7][20] - Medical practice solutions revenue increased by 6% year-over-year, reaching BRL 171 million [7][23] Market Data and Key Metrics Changes - The ecosystem reached 301,000 active users, reflecting strong engagement among physicians and medical students across Brazil [7][9] - The number of active payers in medical practice solutions reached 196,000, with physicians making over 16.9 million prescriptions using the solutions [9][23] Company Strategy and Development Direction - The company aims to strengthen its position across the entire physician lifecycle, expanding its audience and deepening engagement [11][12] - Investments will focus on integrating products and services for physicians, enhancing the user experience, and creating a unified platform [36][37] - The company plans to maintain a balanced capital allocation strategy, focusing on sustainable cash generation, growth investments, and shareholder returns [10][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving another strong year in 2026, with revenue guidance between BRL 3.95 billion and BRL 4.1 billion [16][17] - The company does not expect any material impact from ENAMED on its 2026 guidance, with preparations in place for upcoming evaluations [17][46] - Management highlighted the importance of integrating technology and enhancing product offerings to drive future growth [36][37] Other Important Information - A cash dividend of BRL 307.4 million was announced, representing 40% of the 2025 net income, payable in April 2026 [10][11] - The company maintains a conservative leverage profile with a net debt of BRL 1,369 million, a reduction of BRL 445 million from the end of 2024 [29] Q&A Session All Questions and Answers Question: Focus on continuing education and medical practice solutions transformation - Management discussed integrating products and services for physicians under a unified platform, enhancing user experience and audience engagement [36][37] Question: Progress on ENAMED and PROFIMED discussions - Management indicated no expected impact from ENAMED on 2026 guidance and detailed preparations for upcoming evaluations [46][48] Question: Operational expenses and CapEx increase - Management explained that the increase in intangible assets was due to new investment programs initiated in Q4 2025, and operational expenses were managed effectively [55][56] Question: Capital allocation priorities - Management emphasized the flexibility in capital allocation due to strong free cash flow, focusing on M&A, dividends, and share buybacks [62][63] Question: Revenue growth breakdown by segment - Management provided insights that undergraduate growth would be in single digits, while continuing education and SPM segments would see double-digit growth [75]

Financial Data and Key Metrics Changes - Revenue for the 12-month period grew 12% year-over-year, reaching BRL 3,697 million, with adjusted EBITDA growth of over 50% year-over-year, reaching BRL 1,680 million [4][5] - Adjusted EBITDA margin for the same period reached 45.4%, an increase of 130 basis points over last year [4][5] - Net income reached BRL 768.4 million, an 18% growth year-over-year, with basic EPS reaching BRL 8.32, a 19% increase compared to last year [5][27] - Cash flow from operating activities ended the 12-month period at BRL 1,548 million, over 6% higher than last year, with a cash conversion of 93.7% [4][26] Business Line Data and Key Metrics Changes - The undergraduate segment reported revenue of BRL 2,789 million, up 13% year-over-year, driven by higher ticket prices and the maturation of medical school seats [19][20] - Continuing education revenue reached BRL 284 million, reflecting an 11% growth year-over-year, with B2B revenue growing by 48% [6][22] - Medical practice solutions revenue increased by 6% year-over-year, reaching BRL 171 million [6][24] Market Data and Key Metrics Changes - The ecosystem reached 301,000 active users, indicating strong engagement among physicians and medical students across Brazil [6][9] - The number of medical students grew by 5% year-over-year, exceeding 25,000 students [5][19] Company Strategy and Development Direction - The company aims to strengthen its position across the entire physician lifecycle, expanding its audience and deepening engagement [11][12] - Investments will focus on integrating products and services for physicians, enhancing the user experience, and improving technology and data capabilities [12][37] - The strategy includes scaling B2P healthcare offerings and maintaining a low customer acquisition cost for undergraduate students [13][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver solid results with high predictability, expecting revenue for 2026 to range between BRL 3.95 billion and BRL 4.1 billion [16][17] - The company does not anticipate any material impact from Enamed on its 2026 guidance, with preparations in place for upcoming evaluations [17][46] Other Important Information - A cash dividend of BRL 307.4 million was announced, equivalent to BRL 3.45 per share, representing 40% of the 2025 net income [10][11] - The company maintains a conservative leverage profile with a net debt of BRL 1,369 million, a reduction of BRL 445 million from the end of 2024 [29][30] Q&A Session Summary Question: Transformation in Continuing Education and Medical Practice Solutions - Management discussed integrating products and services for physicians under a unified platform to enhance user experience and audience engagement [36][37] Question: Progress on Enamed and M&A Strategy - Management indicated no expected impact from Enamed on 2026 guidance and outlined plans for M&A to add 200 seats capacity per year targeting educational institutions with significant revenue from medicine programs [46][50] Question: Operational Expenses and CapEx - Management explained that the increase in intangible assets in CapEx was due to new investment programs initiated in Q4 2025, and operational expenses were managed effectively [55][56] Question: Capital Allocation Priorities - Management emphasized the flexibility in capital allocation due to strong free cash flow, balancing investments in M&A, dividends, and share buybacks [61][64] Question: Revenue Growth Breakdown - Management provided insights that undergraduate growth would be in single digits, while medical practice solutions and continuing education would see double-digit growth [71][72]

Financial Data and Key Metrics Changes - For fiscal 2025, revenues declined by 9.5%, primarily due to continued weakness in the truck sector, which accounted for 44% of Core's product sales [16] - Fourth quarter revenue was $74.7 million, representing a 27.8% sequential increase and 19.5% year-over-year growth [13] - Adjusted EBITDA margin for the fourth quarter was 10.2%, an increase of 100 basis points from the previous year [13] - Cash flow from operations totaled over $19 million in 2025, following $35 million generated in fiscal 2024 [14] Business Line Data and Key Metrics Changes - The Invest For Growth initiative generated $63 million in business wins, supporting the strategic diversification strategy [8] - The sheet molding compound (SMC) business generated $12 million in annual revenue during the fourth quarter and $21 million for the full year [9] - Tooling revenue in the fourth quarter exceeded $19 million, driven by recent business wins [17] Market Data and Key Metrics Changes - Early signs of recovery in the powersports industry were noted, with major OEMs launching multiple products that include Core's content [8] - The truck and powersports market is expected to see recovery in volume starting in the second half of 2026 [12] Company Strategy and Development Direction - The company is focused on leveraging its robust foundation to drive growth, with a strong emphasis on disciplined execution and a performance-driven culture [6] - Core aims to achieve $500 million in annual revenue as part of its long-term objectives, targeting large, diverse end markets [25] - The company is strategically diversifying beyond truck and powersports end markets to strengthen its portfolio resilience [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term direction of the company, supported by recent wins and a strong leadership team [7] - The company anticipates total product revenue could exceed $300 million in 2027, driven by new program launches [13] - Management remains conservative regarding the truck recovery, aligning with forecasts indicating a recovery starting in the second half of 2026 [21] Other Important Information - The company completed its footprint optimization initiative and consolidated its resin transfer molding operations to improve margin [14] - Total liquidity as of December 31st was $88.1 million, with a debt to EBITDA ratio of less than one times [20] - The company plans to incur approximately $2.5 million in one-time SG&A costs related to the Mexico relocation and succession planning [22] Q&A Session Summary Question: Can you help us think about the split or the tooling revenue potential in 2026? - The split will be similar to 2025, mainly due to the Volvo program expected to close tooling revenue in Q4 of 2026 [31] Question: Is there ability to go beyond the 17%-19% margin as volumes recover? - Management indicated that margins could improve by 150-200 basis points, potentially reaching low 20s% [34] Question: What are you seeing in the SMC sales channel? - The company is confident in the SMC sales channel, with a successful $21 million annual run rate and additional projects in the pipeline [40] Question: Any updates on the expansion in Mexico? - The expansion has been smooth, with the new plant already shipping products [43] Question: What led to the reduction in SG&A in Q4? - The reduction was due to layoffs and lower severance costs compared to the previous year [80] Question: Can you provide more details on the powersports market rebound? - The powersports market is recovering from a lull, with increased production and new product launches contributing to growth [84]

DISCLAIMER This document ("document") has been prepared by Techtronic Industries Company Limited (the "Company" or "TTI", and together with its subsidiaries, the "Group") solely for use at the presentation held in connection with the announcement of the Company's financial results (the "Presentation"). References to "document" in this disclaimer shall be construed to include any oral commentary, statements, questions, answers and responses at the Presentation. No representation or warranty expressed or impl ...

Financial Data and Key Metrics Changes - The company reported full year 2025 Adjusted EBITDA of $172 million, exceeding previous guidance, with fourth quarter Adjusted EBITDA of $51 million, an 8% increase year-over-year [9][10] - Fourth quarter sales reached $199 million, up $51 million or 34%, with a 15% increase when excluding the $28 million impact of higher sulfur costs [10][11] - The net debt leverage ratio at year-end was 1.2 times, following the repayment of $465 million of term loans from the divestiture proceeds [4][14] Business Line Data and Key Metrics Changes - Sales of virgin sulfuric acid increased significantly, driven by the acquisition of Waggaman assets, while regeneration services faced challenges due to unplanned customer downtime [4][10][23] - The company expects higher sales volume for both virgin and regenerated sulfuric acid in 2026, with stable pricing for virgin sulfuric acid and favorable contractual pricing for regenerated sulfuric acid [5][16] Market Data and Key Metrics Changes - The demand outlook for 2026 remains positive, particularly in mining, which accounts for 20%-25% of sulfuric acid sales, with expectations of increased demand for copper [6][7] - The company anticipates a balanced market for sulfuric acid, with stable pricing and rising demand in mining, while expressing caution regarding industrial applications, particularly nylon [46][47] Company Strategy and Development Direction - The divestiture of the Advanced Materials & Catalysts segment is seen as a transformative event, allowing the company to focus on sulfur solutions for clean fuels and critical materials [5][24] - The company plans to invest approximately $20 million in growth capital in the Gulf Coast region to enhance storage capacity and logistics, supporting mining industry needs [8][24] - A disciplined approach towards inorganic growth is emphasized, with a focus on accretive acquisitions that extend customer reach [56][67] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the demand for sulfuric acid, particularly in mining, while remaining cautious about potential weaknesses in industrial applications [6][37] - The company expects full year sales in 2026 to range between $860 million and $940 million, with Adjusted EBITDA projected between $175 million and $195 million [16][17] Other Important Information - The company repurchased approximately $50 million in common stock in 2025 and plans to continue this strategy in 2026 with additional repurchases [25] - The integration of the Waggaman assets is expected to enhance the supply network and support anticipated growth in demand [22][60] Q&A Session Summary Question: Can you help us think about the Waggaman opportunities and capacity? - The Waggaman assets added roughly 10% volume to the overall network and have improved the supply chain's flexibility [27][28] Question: Can you quantify the regen contract pricing lift for 2026? - The company expects a similar lift in contractual pricing as seen in 2025, typically between 15% and 20% annually [30][31] Question: What factors are contributing to caution regarding industrial applications? - Management noted a general sense of caution due to diverse industrial applications and potential macroeconomic impacts, particularly in the nylon sector [36][37] Question: How do you view the current state of the merchant acid market? - The market is currently balanced, with stable pricing, although some industrial applications may vary [46][47] Question: What would drive the low and high ends of your guidance range? - The high end could be driven by increased virgin acid pricing and healthy regeneration activity, while the low end could result from unplanned outages or macroeconomic events [51][53] Question: What is the long-term view on M&A opportunities? - The company is interested in both organic growth and accretive acquisitions that enhance service capabilities and market reach [55][67]

Financial Data and Key Metrics Changes - Adjusted EBITDA for 2025 was $395 million, exceeding guidance and reflecting strong operating results [4][16] - Q4 revenue reached $2.4 billion, a 9.2% increase year-over-year, while full-year revenue increased by 8.2% to $9.2 billion [13][14] - Net income for Q4 improved to $6 million from a loss of $31.6 million in the prior year, but full-year net income decreased to $82 million from $143 million due to non-operational items [14][15] Business Line Data and Key Metrics Changes - Fresh Fruit segment delivered EBITDA of $189 million for the full year, impacted by higher sourcing costs and weather-related disruptions [9] - Diversified EMEA segment achieved an Adjusted EBITDA of $150 million, a 14% increase year-over-year, driven by strong performance in Spain and the Nordics [10] - Diversified Americas segment saw a 21% increase in full-year Adjusted EBITDA, supported by strong revenue growth in North America [11][12] Market Data and Key Metrics Changes - Demand for bananas remained robust in North America and Europe, while pineapple innovation contributed positively to the category [9] - The EMEA segment benefited from product diversification and market expansion, particularly in Spain and the Nordics [10] - The Americas segment experienced strong growth in commodities, particularly kiwis and cherries, with improved profitability from joint ventures [12] Company Strategy and Development Direction - The company successfully exited the Fresh Vegetables business, allowing for a more focused capital allocation strategy [5] - A $100 million share repurchase program was approved to enhance capital allocation [6] - The company aims to target Adjusted EBITDA of at least $400 million for 2026, focusing on cost control and operational efficiencies [24][23] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by elevated sourcing costs and weather-related disruptions but expressed optimism for recovery in 2026 [9][31] - The company is focused on maintaining operational momentum and executing its development pipeline while navigating macroeconomic uncertainties [24][23] - Management highlighted the importance of strategic investments and operational efficiencies to drive future growth [24][44] Other Important Information - The company transitioned to full U.S. domestic issuer filings, which is expected to improve eligibility for inclusion in U.S. equity indices [7] - A successful launch of the Calado Royale pineapple variety was noted as a significant operational development [8] Q&A Session Summary Question: Could you elaborate on the major factors in your 2026 outlook? - Management discussed the complexities of supply dynamics and the hope for improved production from Honduran farms, while acknowledging ongoing challenges with sourcing costs [26][28][30] Question: What is the expected cash flow conversion relative to EBITDA? - Management indicated a target for free cash flow conversion of 30% to 35% over the long term, with expectations for normalized cash generation in 2026 [32][34] Question: Can you provide details on the Ecuador port asset sale? - Management explained that the sale would be neutral in terms of cost and emphasized a focus on capital allocation priorities, including potential investments in automation and production [42][44] Question: What are the key milestones for index inclusion? - Management expressed confidence in qualifying for inclusion in smaller S&P indices and MSCI indices, with a focus on working towards S&P 600 inclusion [50][51]

Financial Data and Key Metrics Changes - Adjusted EBITDA for 2025 was $395 million, exceeding guidance and reflecting strong operating results [4][16] - Q4 Adjusted EBITDA was $72.7 million, surpassing expectations, with revenue of $2.4 billion, a 9.2% increase year-over-year [13][14] - Full-year revenue increased by 8.2% to $9.2 billion, while net income for the year decreased to $82 million from $143 million due to non-operational items [14][16] Business Line Data and Key Metrics Changes - Fresh Fruit segment delivered EBITDA of $189 million for 2025, impacted by elevated sourcing costs but supported by strong banana demand [9][17] - Diversified EMEA segment achieved an Adjusted EBITDA of $150 million, a 14% increase year-on-year, driven by strong performance in Spain and the Nordics [10][11] - Diversified Americas segment saw a 21% increase in full-year Adjusted EBITDA, driven by strong revenue growth in North America [11][18] Market Data and Key Metrics Changes - The banana market remains robust in North America and Europe, with strong demand supporting pricing despite sourcing challenges [9][10] - The EMEA segment benefited from favorable foreign exchange impacts and strong underlying performance in key markets [17] - The Americas segment experienced excellent product-led growth, particularly in kiwis and citrus [11][18] Company Strategy and Development Direction - The company successfully exited the Fresh Vegetables business, allowing for a more focused capital allocation strategy [5][6] - A $100 million share repurchase program was approved to enhance capital allocation flexibility [6][22] - The company aims to target Adjusted EBITDA of at least $400 million for 2026, focusing on cost control and operational efficiencies [24][25] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by elevated sourcing costs and weather-related disruptions but expressed optimism for recovery in 2026 [9][29] - The company is focused on maintaining operational momentum and leveraging strategic investments to drive growth [23][24] - Management highlighted the importance of navigating macroeconomic uncertainties while targeting growth in core business areas [25][60] Other Important Information - The company completed a $1.2 billion renewal of credit facilities, enhancing financial capacity for future growth initiatives [5] - Cash capital expenditure for 2025 was $121.5 million, with a forecast of approximately $100 million for 2026 [21][20] - The company transitioned to full U.S. domestic issuer filings, which is expected to improve eligibility for inclusion in broader U.S. equity indices [6][52] Q&A Session Summary Question: Could you elaborate on the major factors in your 2026 outlook? - Management noted that while demand trends are robust, fruit sourcing costs remain a challenge, and they are engaging in constructive dialogue with customers regarding pricing [27][29] Question: What is the expected cash flow conversion relative to the $400 million EBITDA target? - Management indicated a target for free cash flow conversion of 30% to 35% over the longer term, with expectations for more normalized levels in 2026 [33][35] Question: Can you discuss the impact of the Ecuador port asset sales on cost structure and capital allocation? - Management stated that the sale would be neutral from a cost perspective and emphasized a dynamic capital allocation process focusing on growth opportunities [43][44] Question: What are the key milestones for index inclusion? - Management expressed optimism about seeking inclusion in smaller S&P indices and MSCI indices, with a focus on the S&P 600 [51][53]

Financial Data and Key Metrics Changes - In 2025, the company increased tons shipped by 6.2%, resulting in record tons sold of 6.4 million, outperforming the industry by over seven percentage points [3][4] - The non-GAAP gross profit margin for 2025 was 28.8%, just outside the estimated sustainable range, primarily due to tariff-driven annual LIFO expense of $114 million [5][6] - Full-year 2025 earnings per diluted share declined 10.2% from 2024, but excluding significant LIFO adjustments, non-GAAP FIFO earnings per diluted share increased 13.5% year-over-year [6][8] - The company generated $831 million in operating cash flow in 2025, with a capital expenditure budget of $275 million for 2026 [7][8] Business Line Data and Key Metrics Changes - Shipment growth was primarily in carbon long and flat-rolled products, with an increase in gross profit margin year-over-year [4] - The company processed 7.4 million customer-owned tons through tolling operations, a 1.2% increase [3] - The fourth quarter tons sold declined 5.4% from the third quarter of 2025 but increased 5.8% from the fourth quarter of 2024 [11] Market Data and Key Metrics Changes - Non-residential construction represented roughly one-third of fourth quarter sales, supported by demand in heavy civil and public infrastructure work [12] - Aerospace products accounted for approximately 10% of fourth quarter sales, with commercial aerospace demand remaining subdued [13] - The semiconductor market remained under pressure due to ongoing excess inventory in the supply chain during the fourth quarter [14] Company Strategy and Development Direction - The company remains committed to returning capital to stockholders, delivering $849 million in 2025 through dividends and share repurchases [8] - The diversified business model and unrivaled scale help offset market-specific weaknesses and support stable performance through economic cycles [8] - The company is focused on maximizing returns on significant capital deployed in recent years and pursuing acquisitions of profitable businesses [7][8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2026, citing healthy demand and strong pricing environment, particularly in infrastructure, data centers, energy, and defense [8][9] - The company anticipates first quarter 2026 tons sold will be up 5%-7% compared to the fourth quarter of 2025, with average selling price per ton expected to improve by 3%-5% [20][21] - Management acknowledged temporary margin headwinds from tariff-driven cost increases and excess inventory in certain markets but noted overall positive impacts from tariffs [22] Other Important Information - The company increased its dividend by 4% to an annual rate of $5 per share in the first quarter of 2026 [8] - The total debt at the end of the year was $1.4 billion, with a favorable net debt to EBITDA ratio of less than one [18][19] Q&A Session Summary Question: Gross profit margin outlook for the rest of the year - Management indicated that while Q1 2026 may be near the low end of the margin range, they expect margins to trend up as demand improves [24][27] Question: Volume growth expectations for the second half of the year - Management is positive about 2026 based on quoting activity and customer purchasing behavior, particularly in carbon products [29][30] Question: Demand for structural products - Demand for structural beams is strong, with recent price increases due to non-residential market demand [36] Question: Semiconductor inventory situation - Management expects slight improvement in semiconductor demand by late 2026 as inventory levels are worked through [41] Question: M&A environment and valuations - The company remains interested in acquisitions but noted that valuations can vary, impacting deal closures [46][49] Question: Impact of aerospace and semiconductor markets on gross margins - Aerospace and semiconductor markets contributed to a 50 basis point impact on overall margins, with less than 15% of overall sales from these segments [56] Question: Headcount and hiring environment - The company experienced a slight decrease in headcount but noted improvements in the labor market, making it easier to fill positions [82]

Financial Data and Key Metrics Changes - In Q4 2025, the company reported net sales of $567 million, EBITDA of $50 million, and adjusted diluted earnings per share of $0.03 [6][7] - For the full year, net sales reached $2.7 billion, with EBITDA of $436 million and adjusted earnings per share of $2.65 [16][17] - The EBITDA margin for the siding business improved to 26%, up 1 percentage point from 2024 [15] Business Line Data and Key Metrics Changes - The siding business grew by 8% for the full year, with a 4% increase in both net selling prices and sales volumes [7][15] - ExpertFinish saw a significant volume increase of 35% in Q4, while prime volumes declined by 5% [13] - OSB operations faced challenges with a year-over-year revenue decrease of $129 million and EBITDA decline of $95 million due to unfavorable supply-demand dynamics [15] Market Data and Key Metrics Changes - Single-family housing starts were down approximately 10% in Q3 2025, with further weakness expected in Q4 [6] - The company noted a stronger market presence in the Upper Midwest, which helped mitigate impacts from softer markets in the Southeast [9] - OSB prices reached their lowest levels in 20 years, significantly impacting revenue [10] Company Strategy and Development Direction - The company aims to drive growth, gain market share, and deliver product innovation while generating shareholder value [5] - Integration of operations under a chief commercial officer and chief operating officer structure is expected to enhance sales synergies and operational efficiency [11] - The company plans to invest approximately $400 million in capital expenditures for 2026, focusing on sustaining maintenance and strategic growth [23] Management's Comments on Operating Environment and Future Outlook - Management acknowledged affordability challenges due to tariffs and economic uncertainty affecting consumer confidence [5] - The company anticipates a difficult first quarter in 2026, with expected volume declines of 15%-20% [20] - Despite current challenges, management remains confident in the long-term growth potential of the SmartSide product line [24] Other Important Information - The company achieved a total incident rate of 0.62 in 2025, earning the APA's Safest Company Award for the third consecutive year [12] - The cash balance at year-end was $292 million, with an undrawn revolver of $750 million, providing over $1 billion in liquidity [17] Q&A Session Summary Question: What factors are influencing siding revenue guidance? - Management expects improvement in shed demand to be the dominant factor, alongside overall housing normalization [27][28] Question: Are there risks of a shift to lower-cost siding materials? - Affordability remains a headwind, with some movement towards vinyl, but the company believes in the value of its SmartSide offerings [29][30] Question: What is the demand outlook for the ExpertFinish product? - Demand remains strong, with macro trends favoring the product, and the company has come off allocation due to operational improvements [33][34] Question: How is the competitive environment in siding evolving? - The company is gaining market share across segments, with a focus on new construction and repair/remodel markets [43][44] Question: What is the outlook for OSB demand and capacity management? - The company is focused on matching supply with demand, with optimism for a rebound in prices and demand as the building season approaches [69][70]

Financial Data and Key Metrics Changes - In Q4 2025, revenues grew by 7.3%, driven by better-than-expected contributions from pricing, volume, and M&A, despite headwinds from foreign exchange [13] - Adjusted EBITDA for the full year reached $1.985 billion, with a 30% Adjusted EBITDA margin, marking a 130 basis point increase over 2024 [7][9] - Adjusted Free Cash Flow for Q4 was $425 million, totaling $756 million for 2025, ahead of plan due to EBITDA outperformance [16] Business Line Data and Key Metrics Changes - Q4 pricing was 6.4% for the quarter and 6.1% for the year, exceeding original plans by 70 basis points [13] - Adjusted EBITDA margins in the Canadian segment increased by 175 basis points, while U.S. margins were up 10 basis points, excluding prior year hurricane volumes [15] Market Data and Key Metrics Changes - Q4 volumes were 70 basis points ahead of plan, attributed to unanticipated special waste activity [14] - C&D-related volume remained soft, but the company is positioned for recovery when the economy improves [15] Company Strategy and Development Direction - The company aims to achieve low- to mid-30s margins by 2028, with a focus on operational efficiency and capital allocation strategy [9][11] - The relocation of the executive headquarters to the U.S. is expected to enhance visibility with investors and broaden eligibility for U.S. equity indices [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the pricing environment and the ability to maintain pricing above internal cost inflation [8] - The company anticipates multiple avenues of upside to the 2026 guidance, with expected revenue of approximately $7 billion, an 8% increase over 2025 [18] Other Important Information - The company completed nearly $1 billion in M&A and bought back over 10% of its own stock, resulting in the lowest year-end net leverage in its history at 3.4x [10][11] - Adjusted Free Cash Flow for 2026 is expected to increase to $835 million, reflecting a 14% growth [20] Q&A Session Summary Question: Does the leverage guidance assume no incremental M&A and buyback? - Management confirmed that the leverage guidance is committed to low to mid threes, and any incremental M&A or buybacks would increase that number [24] Question: Can you break down the EBITDA bridge for 2026? - Management acknowledged the components affecting EBITDA, including M&A rollover benefits and FX impacts, indicating organic EBITDA growth in the mid- to high single digits is achievable [25][27] Question: What is the expected contribution from EPR and R&G investments? - Management indicated that EPR contributions are expected to ramp up significantly in 2026, while R&G contributions are more muted and will ramp up into 2027 [33][34] Question: How do you balance M&A and share buybacks? - Management stated that while the stock is undervalued, they will continue to evaluate both M&A opportunities and share buybacks based on market conditions [40][41] Question: How is the M&A pipeline looking for 2026? - Management reported a healthy M&A pipeline focused on businesses in existing markets, with expectations of deploying $750 million to $1 billion in acquisitions [65] Question: Will there be incremental disclosure on GIP and ES performance? - Management committed to providing more detailed disclosures on GIP and ES performance in future quarterly releases [82]